Skip to Content
Exit Menu
Dr Sara Anjomani-Virmouni

Dr Sara Anjomani-Virmouni
Lecturer in Biomedical Sciences

Research area(s)

Neurodegenerative diseases, Friedreich’s ataxia, Epigenetics and Metabolomics

Research Interests

The Ataxia Research Group investigates molecular disease mechanisms and therapy for the inherited disorder, Friedreich’s ataxia (FRDA). Currently, the lab is focused on five projects:

  • Metabolomics analysis of FRDA cells
  • Proteome/phosphoproteome analysis of FRDA cells
  • Cell and gene therapy for FRDA
  • Therapeutic potential of different antioxidants in FRDA
  • Development and characterisation of GAA repeat-based FRDA transgenic mouse models

Team:

Senior Research Fellow

  • Dr Sahar Al-Mahdawi

Postdoctoral Researcher

  • Dr Ester Kalef-Ezra

PhD Students

  • Mr Fred Edzeamey
  • Ms Zeynep Ulukutuk 

Research grants and projects

Research Projects

Grants

Sphingolipid Rheostat as a Potential Target for Friedreich’s Ataxia
Funder: Friedreich's Ataxia Research Alliance
Duration: October 2021 - October 2023
Investigating the role of bioactive sphingolipids in Friedreich’s ataxia (FRDA)
Funder: Ataxia UK
Duration: January 2021 - July 2021

Project Grant

Visiting Research Grant
Funder: Universitat de les Illes Balears
Duration: September 2020 - July 2021
Comprehensive phosphoproteome analysis of Friedreich’s ataxia cells
Funder: Brunel BRIEF Award
Duration: September 2019 - September 2021
A new cell and gene therapy approach for Friedreich's ataxia
Funder: Medical Research Council
Duration: May 2019 - April 2021
Elucidation of the metabolic signature of Friedreich’s ataxia
Funder: FARA-US
Duration: April 2018 - June 2021

Research links

Research group(s)

  • IEHS